Bluesight Expands Compliance Capabilities with Protenus Acquisition
Deal News | Jan 09, 2025 | Thoma Bravo
Bluesight, a leader in inventory management and compliance solutions for health systems, has acquired Protenus, a top healthcare compliance analytics platform. This acquisition strategically strengthens Bluesight's drug diversion platform and adds vital patient privacy monitoring capabilities. Protenus, founded in 2014, is renowned for leveraging AI to provide healthcare organizations with risk-reduction solutions, ensuring quality patient outcomes while safeguarding reputations. The merger will enhance compliance and operational efficiency in healthcare settings. Baird acted as financial advisor for Protenus, with legal services from Kirkland & Ellis LLP and DLA Piper LLP.
Sectors
- Healthcare Technology
- Pharmacy Automation & Management
- Artificial Intelligence
Geography
- United States – Both Bluesight and Protenus are described as operating and having strong relationships with healthcare organizations across the United States.
- Canada – Bluesight's services are mentioned to support Canadian hospitals as well.
Industry
- Healthcare Technology – The article discusses companies that provide technology solutions for the healthcare sector, focusing on compliance, inventory management, and risk reduction.
- Pharmacy Automation & Management – Bluesight specializes in inventory management and procurement solutions for hospital pharmacies, making this a relevant industry classification.
- Artificial Intelligence – Protenus leverages AI for healthcare compliance analytics, offering scalable risk-reduction solutions.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Bluesight | Acquirer | Company | A leading provider of inventory management, procurement, and compliance solutions for health systems and hospital pharmacies. |
| Protenus | Target Company | Company | Provider of a healthcare compliance analytics platform, leveraging AI for scalable risk-reduction solutions. |
| Thoma Bravo | Private Equity Firm | Company | A private equity firm backing Bluesight in its acquisition endeavors. |
| Baird | Financial Advisor | Company | Served as financial advisor to Protenus. |
| Kirkland & Ellis LLP | Legal Counsel | Company | Provided legal counsel for Thoma Bravo & Bluesight. |
| DLA Piper LLP | Legal Counsel | Company | Provided legal counsel for Protenus. |